Department of Thoracic Surgery, Medical Center-University of Freiburg, 79106 Freiburg im Breisgau, Germany.
Faculty of Medicine, University of Freiburg, 79106 Freiburg im Breisgau, Germany.
Curr Oncol. 2022 Jun 26;29(7):4511-4521. doi: 10.3390/curroncol29070357.
Background: Pulmonary metastasectomy (PM) is an established treatment option for selected patients with stage IV solid tumors. The aim of this study was to investigate the feasibility of and survival rate in PM for elderly patients. Methods: We retrospectively analyzed all of the patients who underwent PM with curative intention at our institution. The patients were categorized into two groups: the elderly group (≥70 years old) and the non-elderly group (<70 years old). Results: The elderly group consisted of 222 patients versus 538 patients in the non-elderly group. The median number of resected metastases was 2 ± 3 in the elderly group and 4 ± 5 in the non-elderly group (p < 0.01). No difference in the rate of postoperative complications was observed between the two groups (p = 0.3). The median length of hospital stay in each group was comparable (10 ± 5 vs. 10 ± 4.3 days, p = 0.3). The 5-year survival rate was 67% in the elderly group and 78% in the non-elderly group (p = 0.117). In the univariate analysis, COPD was associated with poor survival in the elderly group (p = 0.002). Conclusion: The resection of pulmonary metastases in elderly patients is safe, is not associated with increased risks of postoperative complication, and the survival benefit is not reduced in selected patients.
肺转移瘤切除术(PM)是一种治疗 IV 期实体肿瘤的既定方法。本研究旨在探讨 PM 治疗老年患者的可行性和生存率。
我们回顾性分析了在我院接受根治性 PM 的所有患者。将患者分为两组:老年组(≥70 岁)和非老年组(<70 岁)。
老年组有 222 例患者,而非老年组有 538 例患者。老年组的中位数转移灶切除数为 2 ± 3,而非老年组为 4 ± 5(p < 0.01)。两组术后并发症发生率无差异(p = 0.3)。两组的中位住院时间相当(10 ± 5 与 10 ± 4.3 天,p = 0.3)。老年组 5 年生存率为 67%,非老年组为 78%(p = 0.117)。单因素分析显示,老年组 COPD 与生存不良相关(p = 0.002)。
在选择合适的老年患者中,切除肺转移瘤是安全的,与术后并发症风险增加无关,并且生存获益并未降低。